ROIV
ROIVANT SCIENCES (ROIV)
NASDAQ
$35.87-$0.62 (-1.71%)
Price as of Oct 26, 2026 5:14 PM EDT
  • $26.0B
    Market Cap
  • 100.27%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
FMR LLC
11.22%
81.0M
+3.0M (+3.75%)
Jun 30, 2026
BLACKROCK, INC.
6.68%
48.2M
+4.0M (+8.25%)
Jun 30, 2026
MORGAN STANLEY
5.90%
42.6M
-9.2M (-21.68%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
5.84%
42.2M
+195,472 (+0.46%)
Dec 31, 2024
VANGUARD GROUP INC
5.82%
42.1M
+3.3M (+7.74%)
Dec 31, 2025
BLACKROCK INC.
4.90%
35.4M
-817,249 (-2.31%)
Jun 30, 2024
QVT FINANCIAL LP
3.28%
23.7M
-1.4M (-6.06%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions9.3B (85.46%)
  • Mutual Funds980.1M (9.04%)
  • Insiders597.6M (5.51%)
  • Other0 (0.00%)

Insider Transactions

  • 5.51% (597.6M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 11
    Number of InsiderSelling (last 12 months)
  • $25.5B
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Gline Matthew
CEO
In Kind
Oct 16, 2026
$1.2M
34,638
$33.53
16.5M
Sukhatme Mayukh
President & CIO
In Kind
Oct 16, 2026
$669,795.28
19,976
$33.53
18.6M
Epperly Melissa B,
Exempt
Oct 01, 2026
$0.00
17,750
$0.00
151,416
Epperly Melissa B,
Exempt
Oct 01, 2026
$79,165.00
17,750
$4.46
32,704
Epperly Melissa B,
Sell
Oct 01, 2026
$607,948.00
16,850
$36.08
15,854
Epperly Melissa B,
Sell
Oct 01, 2026
$32,913.00
900
$36.57
14,954
Venker Eric
President & Immunovant CEO
Exempt
Sep 30, 2026
$0.00
200,000
$0.00
3.6M
Gline Matthew
CEO
In Kind
Sep 30, 2026
$2.8M
76,171
$36.57
16.6M
Venker Eric
President & Immunovant CEO
Exempt
Sep 30, 2026
$770,000.00
200,000
$3.85
1.8M
Venker Eric
President & Immunovant CEO
Sell
Sep 30, 2026
$7.3M
200,000
$36.62
1.6M
Humes Jennifer
Chief Accounting Officer
In Kind
Sep 20, 2026
$154,307.60
3,880
$39.77
106,419
Pulik Richard
CFO
In Kind
Sep 20, 2026
$84,670.33
2,129
$39.77
269,681
Gold Daniel Allen
Award
Sep 16, 2026
$0.00
10,531
$0.00
10,531
Epperly Melissa B,
Award
Sep 16, 2026
$0.00
10,531
$0.00
10,531
Gold Daniel Allen
Award
Sep 16, 2026
$0.00
5,054
$0.00
9.0M
MANCHESTER KEITH S
Award
Sep 16, 2026
$0.00
10,531
$0.00
10,531
Epperly Melissa B,
Award
Sep 16, 2026
$0.00
5,054
$0.00
14,954
MANCHESTER KEITH S
Award
Sep 16, 2026
$0.00
5,054
$0.00
1.8M
Epperly Melissa B,
Sell
Sep 15, 2026
$172,001.70
4,338
$39.65
10,500
Epperly Melissa B,
Sell
Sep 15, 2026
$24,228.00
600
$40.38
9,900
Epperly Melissa B,
In Kind
Sep 10, 2026
$89,208.26
2,179
$40.94
14,838
Fitzgerald Meghan
In Kind
Sep 10, 2026
$71,358.42
1,743
$40.94
41,220
Oren Ilan
In Kind
Sep 10, 2026
$97,355.32
2,378
$40.94
118,626
MOMTAZEE JAMES C
In Kind
Sep 10, 2026
$118,930.70
2,905
$40.94
106,905
Venker Eric
President & Immunovant CEO
Exempt
Aug 28, 2026
$0.00
200,000
$0.00
3.8M
Venker Eric
President & Immunovant CEO
Exempt
Aug 28, 2026
$770,000.00
200,000
$3.85
1.8M
Venker Eric
President & Immunovant CEO
Sell
Aug 28, 2026
$5.9M
166,182
$35.63
1.6M
Venker Eric
President & Immunovant CEO
Sell
Aug 28, 2026
$1.2M
33,818
$36.44
1.6M
Sukhatme Mayukh
President & CIO
Exempt
Aug 21, 2026
$0.00
144,756
$0.00
13.2M
Sukhatme Mayukh
President & CIO
Exempt
Aug 21, 2026
$557,310.60
144,756
$3.85
18.8M